Grade: Pharmaceutical Grade
Factory Location: Lianyungang, Jiangsu, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
Daptomycin API and Daptomycin for Injection has been approved by CFDA in Sep, 2016.